TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair

Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2113-27. doi: 10.1152/ajpheart.00879.2008. Epub 2008 Oct 10.

Abstract

Although clinical studies have identified scarring/fibrosis as significant risk factors for lymphedema, the mechanisms by which lymphatic repair is impaired remain unknown. Transforming growth factor -beta1 (TGF-beta1) is a critical regulator of tissue fibrosis/scarring and may therefore also play a role in the regulation of lymphatic regeneration. The purpose of this study was therefore to assess the role of TGF-beta1 on scarring/fibrosis and lymphatic regeneration in a mouse tail model. Acute lymphedema was induced in mouse tails by full-thickness skin excision and lymphatic ligation. TGF-beta1 expression and scarring were modulated by repairing the wounds with or without a topical collagen gel. Lymphatic function and histological analyses were performed at various time points. Finally, the effects of TGF-beta1 on lymphatic endothelial cells (LECs) in vitro were evaluated. As a result, the wound repair with collagen gel significantly reduced the expression of TGF-beta1, decreased scarring/fibrosis, and significantly accelerated lymphatic regeneration. The addition of recombinant TGF-beta1 to the collagen gel negated these effects. The improved lymphatic regeneration secondary to TGF-beta1 inhibition was associated with increased infiltration and proliferation of LECs and macrophages. TGF-beta1 caused a dose-dependent significant decrease in cellular proliferation and tubule formation of isolated LECs without changes in the expression of VEGF-C/D. Finally, the increased expression of TGF-beta1 during wound repair resulted in lymphatic fibrosis and the coexpression of alpha-smooth muscle actin and lymphatic vessel endothelial receptor-1 in regenerated lymphatics. In conclusion, the inhibition of TGF-beta1 expression significantly accelerates lymphatic regeneration during wound healing. An increased TGF-beta1 expression inhibits LEC proliferation and function and promotes lymphatic fibrosis. These findings imply that the clinical interventions that diminish TGF-beta1 expression may be useful in promoting more rapid lymphatic regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Cell Movement
  • Cell Proliferation
  • Cicatrix / metabolism
  • Cicatrix / physiopathology
  • Collagen / administration & dosage
  • Dermatologic Surgical Procedures
  • Endothelium, Lymphatic / metabolism
  • Endothelium, Lymphatic / physiopathology
  • Female
  • Fibroblasts / metabolism
  • Fibrosis
  • Gels
  • Ligation
  • Lymphangiogenesis* / drug effects
  • Lymphatic Vessels / drug effects
  • Lymphatic Vessels / metabolism
  • Lymphatic Vessels / pathology
  • Lymphatic Vessels / physiopathology*
  • Lymphatic Vessels / surgery
  • Lymphedema / metabolism
  • Lymphedema / pathology
  • Lymphedema / physiopathology*
  • Lymphedema / prevention & control
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Recombinant Proteins / metabolism
  • Skin / drug effects
  • Skin / metabolism
  • Skin / pathology
  • Skin / physiopathology*
  • Tail
  • Time Factors
  • Transforming Growth Factor beta1 / metabolism*
  • Wound Healing* / drug effects

Substances

  • Gels
  • Recombinant Proteins
  • Transforming Growth Factor beta1
  • Collagen